Weighted Average Number of Shares Outstanding, Diluted of Achilles Therapeutics plc from 31 Dec 2019 to 30 Jun 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Achilles Therapeutics plc quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2019 to 30 Jun 2024.
  • Achilles Therapeutics plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 40,355,972, a 1.1% increase year-over-year.
  • Achilles Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 39,973,059, a 2.1% increase from 2022.
  • Achilles Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 39,139,693, a 37% increase from 2021.
  • Achilles Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 28,654,760, a 2588% increase from 2020.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Achilles Therapeutics plc Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 40,355,972 +456,028 +1.1% 01 Apr 2024 30 Jun 2024 6-K 14 Aug 2024 2024 Q2
Q2 2023 39,899,944 +795,569 +2% 01 Apr 2023 30 Jun 2023 6-K 14 Aug 2024 2024 Q2
Q2 2022 39,104,375 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023

Achilles Therapeutics plc Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 39,973,059 +833,366 +2.1% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2024 2023 FY
2022 39,139,693 +10,484,933 +37% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2024 2023 FY
2021 28,654,760 +27,588,552 +2588% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024 2023 FY
2020 1,066,208 +424,039 +66% 01 Jan 2020 31 Dec 2020 20-F 07 Mar 2023 2022 FY
2019 642,169 01 Jan 2019 31 Dec 2019 20-F 01 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.